Risk factors of atrial fibrillation progression in patients with congenital heart disease - Takeaways - MDSpire

Risk factors of atrial fibrillation progression in patients with congenital heart disease

  • By

  • Can Zhang

  • Nawin L. Ramdat Misier

  • Lixia Dai

  • Manouk H. C. Linderhof

  • Hoang H. Nguyen

  • Annemien E. van den Bosch

  • Vehpi Yildirim

  • Mathijs S. van Schie

  • Yannick J. H. J. Taverne

  • Natasja M. S. de Groot

  • June 29, 2026

  • 0 min

Share

  • 1

    Atrial fibrillation (AF) prevalence in adults with congenital heart disease (CHD) is up to 20 times higher than in the general population.

  • 2

    AF progression in CHD patients is poorly understood, with studies indicating that over 20% of those with paroxysmal AF eventually progress.

  • 3

    The study followed 125 CHD patients for an average of 17 years, finding AF progression in 45.6% of cases.

  • 4

    Patients with AF progression were more likely to be female and had less severe CHD compared to those without progression.

  • 5

    The study highlights the need for further investigation into the factors influencing AF progression in the CHD population.

Original Source(s)

Risk factors of atrial fibrillation progression in patients with congenital heart disease

  • by Can Zhang, Nawin L. Ramdat Misier, Lixia Dai, Manouk H. C. Linderhof, Hoang H. Nguyen, Annemien E. van den Bosch, Vehpi Yildirim, Mathijs S. van Schie, Yannick J. H. J. Taverne, Natasja M. S. de Groot

  • June 29, 2026

Related Content

Depressive symptoms and health-related quality of life following acute myocardial infarction

Can AI Extract Echo Report Data as Accurately as Expert Annotation?

In a study of 50 echocardiography reports, GPT-5 mini extracted 55 cardiovascular fields from free-text echocardiography reports with 92.5% exact-match agreement with expert annotation.

Mavacamten Treatment Associated With Improved Diastolic Function, Remodeling Markers

Real-world follow-up data from 465 patients add to evidence from earlier randomized trials.